Abstract
Eye plaque brachytherapy has been developed and refined for the last 80 years, demonstrating effective results in the treatment of ocular malignancies. Current dosimetry techniques for eye plaque brachytherapy (such as TLD- and film-based techniques) are time consuming and cannot be used prior to treatment in a sterile environment. The measurement of the expected dose distribution within the eye, prior to insertion within the clinical setting, would be advantageous, as any errors in source loading will lead to an erroneous dose distribution and inferior treatment outcomes. This study investigated the use of spectroscopic dosimetry techniques for real-time quality assurance of I-125 based eye plaques, immediately prior to insertion. A silicon detector based probe, operating in spectroscopy mode was constructed, containing a small (1 mm3) silicon detector, mounted within a ceramic holder, all encapsulated within a rubber sheath to prevent water infiltration of the electronics. Preliminary tests of the prototype demonstrated that the depth dose distribution through the central axis of an I-125 based eye plaque may be determined from AAPM Task Group 43 recommendations to a deviation of 6 % at 3 mm depth, 7 % at 5 mm depth, 1 % at 10 mm depth and 13 % at 20 mm depth, with the deviations attributed to the construction of the probe. A new probe design aims to reduce these discrepancies, however the concept of spectroscopic dosimetry shows great promise for use in eye plaque quality assurance in the clinical setting.
Similar content being viewed by others
References
Australian Bureau of Statistics (2008) Population projections, Australia, 2006–2011
McDermid I (2005) In: A.A. Australian Institute of Health and Welfare (AIHW) and o.C.R.A.a.t.N.C.S.G. (NCSG) (eds) Cancer incidence projections, Australia 2002 to 2011. AIHW, AACR & NCSG: Canberra
Chan MF et al (2000) The measurement of three dimensional dose distribution of a ruthenium-106 ophthalmological applicator using magnetic resonance imaging of BANG polymer gels. In: Enderle JD (ed) Proceedings of the 22nd annual international conference of the IEEE Engineering in Medicine and Biology Society, vols 1–4, pp 2431–2432. doi:10.1109/IEMBS.2000.901291
Stallard HB (1949) A Case of malignant melanoma of the choroid successfully treated by radon seeds. Trans Ophthalmol Soc 69:293–296
Green JA (2011) Optimisation of eye plaque dosimetry using Monte Carlo method, in School of Engineering Physics. University of Wollongong, Wollongong, p 158
Nath R et al (1995) Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. Med Phys 22(2):134–209
Council Directive 2013/59/Euratom of 5 December 2013 laying down basic safety standards for protection against the dangers arising from exposure to ionising radiation, and repealing Directives 89/618/Euratom, 96/641/Euratom, 97/43/Euratom and 2003/122/Euratom Official Journal of the European Union 2014
Rivard et al (2004) Update of AAPM task group no. 43 report: a revised AAPM protocol for brachytherapy dose calculations. Med Phys 31(3):633–674. doi:10.1118/1.1646040
Alberti et al (1991) Dosimetry and physical treatment planning for iodine plaque therapy. Int J Radiat Oncol Biol Phys 20(5):1087–1092. doi:10.1016/0360-3016(91)90209-M
Nag S et al (2003) The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas. Int J Radiat Oncol Biol Phys 56(2):544–555. doi:10.1016/S0360-3016(03)00006-3
Sorriaux et al (2013) Evaluation of Gafchromic EBT3 films characteristics in therapy photon, electron and proton beams. Eur J Med Phys 29(6):599–606. doi:10.1016/j.ejmp.2012.10.001
Van Hoof SJ, Granton PV, Landry G, Podesta M, Verhaegan F (2012) Evaluation of a novel triple channel radiochromic film analysis procedure using EBT2. Phys Med Biol. doi:10.1088/0031-9155/57/13/4353
Cutajar D (2011) Spectroscopic dosimetry: the development of the urethral mini-dosimetry system, in School of Engineering Physics. University of Wollongong, Wollongong, p 256
Rozenfeld AB, Zaider M(2011) Method and apparatus for real time dosimetry U.S. Patent No. 7,361,134 2008; US Patent 7,972,259 B2
Sources and their applications in brachytherapy (2004) Report 72, J ICRU, vol 4, no 2. Oxford University Press, Oxford
Cutajar DL, Takacs GJ, Lerch ML, Braddock T, Bucci J, Brady J, Duggan LJ, Enari KE, Zaider M, Zelefsky M, Rosenfeld A (2006) Intraoperative solid-state based urethral dosimetry in low dose rate prostate brachytherapy. IEEE Trans Nucl Sci 53(3):1408–1412. doi:10.1109/TNS.2006.873003
Poder J (2013) Ropes eye plaque dosimetry: commissioning and verification of an ophthalmic brachytherapy treatment planning system. J Phys 444:012102
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jarema, T., Cutajar, D., Weaver, M. et al. Dose verification of eye plaque brachytherapy using spectroscopic dosimetry. Australas Phys Eng Sci Med 39, 627–632 (2016). https://doi.org/10.1007/s13246-016-0453-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13246-016-0453-y